In addition, CTDP1 knockdown interfered with the development of breast cancer cell lines, both in vitro and in vivo [8], underscoring the roles of CTDP1 as a regulator of genome stability and revealing its potential as a therapeutic target in cancer or diseases with impaired DNA damage repair. The gene discussed is CTDP1; the disease is cancer.